Cargando…
Urological cancer patients receiving treatment during COVID-19: a single-centre perspective
BACKGROUND: Active cancer, immunosuppressive treatments and immunotherapies have been reported to increase cancer patients’ risk of developing severe COVID-19 infection. For patients and clinicians, treatment risk must be weighed against disease progression. METHODS: This retrospective case series s...
Autores principales: | Williams, Sophie Therese, El Badri, Salma, Hussain, Syed Anwer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869760/ https://www.ncbi.nlm.nih.gov/pubmed/33558714 http://dx.doi.org/10.1038/s41416-021-01263-7 |
Ejemplares similares
-
Urologic oncology patient perspectives during COVID-19 treatment delays
por: Faris, Anna, et al.
Publicado: (2022) -
Laparoendoscopic single site surgery in urology: A single centre experience
por: Ganpule, Arvind P, et al.
Publicado: (2012) -
Urological manifestations of Chikungunya fever: A single centre experience
por: Baishya, Ramen, et al.
Publicado: (2010) -
Urological complications after renal transplantation – a single centre experience
por: Krajewski, Wojciech, et al.
Publicado: (2016) -
Urological service provision during the COVID-19 period: the experience from an Irish tertiary centre
por: Collins, Patrick M., et al.
Publicado: (2020)